Brookfield Renewable Partners LP
BEP.UN
TELUS Corp
T
BCE Inc
BCE
Enbridge Inc
ENB
TC Energy Corp
TRP
CA Stock MarketDetailed Quotes
BUX Biomark Diagnostics Inc
- 0.240
- 0.0000.00%
15min DelayMarket Closed Mar 7 15:38 ET
21.81MMarket Cap-12.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.240Pre Close0.00Turnover0.31552wk High0.00%Turnover Ratio90.89MShares0.18052wk Low-0.02EPS TTM21.81MFloat Cap1.020Historical HighLossP/E (Static)90.89MShs Float0.025Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM-20.00P/B1Lot Size--Div YieldTTM
Biomark Diagnostics Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 62.51%-189.85K | -1,002.24%-130.64K | -28.39%-320.69K | -7.45%-982.52K | -22.39%-214.47K | -227.80%-506.43K | 95.78%-11.85K | 17.84%-249.77K | 24.05%-914.42K | 63.56%-175.23K |
| Net income from continuing operations | 17.70%-334.77K | -160.05%-547.3K | -48.80%-623.28K | 22.52%-1.43M | 21.97%-391.31K | -3.32%-406.76K | 60.13%-210.46K | 0.07%-418.86K | -26.71%-1.84M | 31.29%-501.51K |
| Depreciation and amortization | -40.94%58.49K | -35.74%58.17K | -43.80%57.76K | 1.81%393.17K | -1.84%100.85K | 9.74%99.04K | -6.30%90.51K | 6.38%102.77K | 115.00%386.2K | -21.15%102.74K |
| Remuneration paid in stock | 0.11%15.81K | 243.73%111.54K | 485.43%209.39K | -77.09%75.48K | -239.77%-8.53K | -87.13%15.8K | -83.83%32.45K | --35.77K | --329.53K | --6.1K |
| Other non cashItems | -12.52%14.15K | 22.20%16.56K | 22.45%18.9K | -15.84%62.66K | -76.86%17.5K | 549.85%16.17K | 168.19%13.55K | -30.75%15.44K | 168.42%74.46K | 386.71%75.64K |
| Change In working capital | 124.48%56.47K | 271.05%230.4K | 9.46%16.54K | -162.81%-86.45K | -52.73%67.02K | -872.98%-230.67K | 305.36%62.09K | 500.45%15.11K | 222.97%137.63K | 37.49%141.8K |
| -Change in receivables | 80.54%-3.35K | -530.81%-36.45K | 21.20%12.01K | -118.12%-8.65K | 136.01%4.43K | -364.19%-17.22K | -174.23%-5.78K | -82.19%9.91K | 186.89%47.76K | 75.58%-12.3K |
| -Change in payables and accrued expense | 128.29%59.82K | 293.16%266.85K | -12.91%4.53K | -186.57%-77.8K | -59.83%60.57K | -1,006.47%-211.43K | 373.72%67.87K | 108.75%5.2K | -20.87%89.87K | 36.35%150.76K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 62.51%-189.85K | -1,002.24%-130.64K | -28.39%-320.69K | -7.45%-982.52K | -22.39%-214.47K | -227.80%-506.43K | 95.78%-11.85K | 17.84%-249.77K | 24.05%-914.42K | 63.56%-175.23K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -2.51K | 17.08%-4.39K | -123,500.00%-1.24K | -190.37%-2.2K | -95,800.00%-957 | 0 | 91.05%-5.3K | -1 |
| Net PPE purchase and sale | --0 | --0 | ---2.51K | 17.08%-4.39K | -123,500.00%-1.24K | -190.37%-2.2K | -95,800.00%-957 | --0 | 91.05%-5.3K | ---1 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | ---2.51K | 17.08%-4.39K | -123,500.00%-1.24K | -190.37%-2.2K | -95,800.00%-957 | --0 | 91.05%-5.3K | ---1 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -62.68%243.79K | 297.61%23.92K | -12.79%307.81K | 75.95%1.07M | -47.59%59.42K | 410.54%653.22K | -92.18%6.02K | 21.38%352.97K | -20.71%609.05K | -83.43%113.36K |
| Net issuance payments of debt | -2.15%-103.26K | 56.18%-102.88K | -1.20%-102.88K | -144.23%-732.64K | -84.38%-295.13K | -27.39%-101.08K | 59.00%-234.76K | -119.86%-101.66K | -86.58%-299.99K | -349.98%-160.07K |
| Net common stock issuance | ---- | ---- | ---- | 155.62%1.54M | --0 | ---- | ---- | ---- | --603.2K | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -84.04%37.5K | --0 |
| Net other financing activities | 144.06%347.04K | -47.34%126.8K | -9.67%410.69K | -2.21%262.4K | 29.67%354.55K | -479.92%-787.57K | 420.01%240.78K | 275.74%454.64K | -61.33%268.34K | -55.92%273.43K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -62.68%243.79K | 297.61%23.92K | -12.79%307.81K | 75.95%1.07M | -47.59%59.42K | 410.54%653.22K | -92.18%6.02K | 21.38%352.97K | -20.71%609.05K | -83.43%113.36K |
| Net cash flow | ||||||||||
| Beginning cash position | -79.43%34.65K | -19.33%141.36K | 117.60%156.75K | -81.18%72.04K | 133.78%313.03K | 4.49%168.45K | -51.98%175.24K | -81.18%72.04K | -56.40%382.71K | -25.32%133.9K |
| Current changes in cash | -62.70%53.94K | -1,471.16%-106.71K | -114.91%-15.39K | 127.27%84.71K | -152.63%-156.28K | 629.49%144.59K | 96.67%-6.79K | 681.24%103.2K | 37.23%-310.67K | -130.41%-61.86K |
| End cash Position | -71.70%88.58K | -79.43%34.65K | -19.33%141.36K | 117.60%156.75K | 117.60%156.75K | 133.78%313.03K | 4.49%168.45K | -51.98%175.24K | -81.18%72.04K | -81.18%72.04K |
| Free cash from | 62.67%-189.85K | -919.88%-130.64K | -29.40%-323.2K | -7.31%-986.92K | -23.10%-215.7K | -227.61%-508.63K | 95.44%-12.81K | 19.05%-249.77K | 27.19%-919.72K | 63.56%-175.23K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.